GPCRs have been shown to have a significant role in the ability of tumour cells to metastasize with a third of the druggable GPCR family shown to promote metastatic cancers (Figure 1 and Figure 2, Table 1). Here, LPAR3 is linked to metastatic malignant neoplasm.